Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil

被引:16
|
作者
Castilho, E. C. D. [1 ]
Reis, A. M. M. [2 ]
Borges, T. L. [1 ]
Siqueira, L. D. C. [3 ]
Miasso, A. I. [1 ]
机构
[1] Univ Sao Paulo, Ribeirao Preto Nursing Sch, Psychiat Nursing & Human Sci Dept, Ribeirao Preto, SP, Brazil
[2] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[3] Grande Dourados Univ Hosp, Dourados, MS, Brazil
关键词
aged; drug interactions; drug therapy; health of the elderly; patient safety; polypharmacy; MEDICATION RECONCILIATION; PSYCHIATRIC-PATIENTS; INAPPROPRIATE MEDICATIONS; PSYCHOTROPIC MEDICATIONS; COHORT; PREVALENCE; FLUOXETINE; ADMISSIONS; MANAGEMENT; PAROXETINE;
D O I
10.1111/jpm.12431
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Accessible Summary What is known on the subject? Older individuals constitute an increasing proportion of the population, and therefore, are the major consumers of drugs. The elderly, especially those with mental disabilities, frequently develop chronic diseases and start using numerous drugs. Drug-drug interactions (DDIs) are a major clinical problem in the elderly population, and previous studies have focused only on antidepressants and others types of drugs used to treat mental health conditions. What this article adds to existing knowledge? This study shows that in hospitalized elderly patients with mental disorders (aged 60-69years), polypharmacy (5 drugs) and the use of drugs that act on the cardiovascular, respiratory and nervous systems can lead to potential drug-drug interactions. Moreover, it was reported that the prevalence of drug-drug interactions in elderly patients with mental disorders was high during their hospitalization in a public hospital in Brazil. What are the implications for practice? Nurses should know the factors associated with drug-drug interactions in hospitalized elderly patients with mental disorders to choose appropriate strategies for avoiding treatment failure and adverse events in patients. Abstract Introduction Despite the impact on patient safety and the fact that prevalence is higher in older patients, previous research did not analyse drug-drug interactions (DDIs) in view of nursing care of elderly psychiatric patients. Aim To identify potential drug-drug interactions and polypharmacy in prescriptions of aged inpatients with psychiatric disorders and analyse associated factors. Methods In this retrospective cross-sectional study, we analysed the medical records of institutionalized patients diagnosed with psychiatric disorders (n=94), aged >60years, and prescribed multiple medications. Drug prescriptions were checked at admission, midway through and the last prescription. Factors associated with DDI occurrence were assessed using multivariable logistic regression analysis. Results A DDI prevalence potential of 67.0%, 74.5% and 80.8% occurred in patients at admission, midway through hospitalization and the last prescription, respectively. Most of the prescribed drugs were nervous system agents. A high percentage of serious and contraindicated potential DDIs occurred. Age between 60 and 69years, use of cardiovascular and respiratory system drugs, and the number of medications contributed significantly to DDI. Implications for mental health nursing Knowledge on the factors associated with DDIs in patients with mental disorders can contribute to the improvement of effectiveness and safety of nursing care.
引用
收藏
页码:3 / 13
页数:11
相关论文
共 50 条
  • [1] Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatry
    Wolff, Jan
    Hefner, Gudrun
    Normann, Claus
    Kaier, Klaus
    Binder, Harald
    Hiemke, Christoph
    Toto, Sermin
    Domschke, Katharina
    Marschollek, Michael
    Klimke, Ansgar
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (09) : 1258 - 1268
  • [2] Polypharmacy and potential drug-drug interactions in emergency department patients in the Caribbean
    Dookeeram, Darren
    Bidaisee, Satesh
    Paul, Joanne F.
    Nunes, Paula
    Robertson, Paula
    Maharaj, Vidya Ramcharitar
    Sammy, Ian
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (05) : 1119 - 1127
  • [3] Drug-drug interactions in a cohort of hospitalized elderly patients
    Pasina, Luca
    Djade, Codjo D.
    Nobili, Alessandro
    Tettamanti, Mauro
    Franchi, Carlotta
    Salerno, Francesco
    Corrao, Salvatore
    Marengoni, Alessandra
    Iorio, Alfonso
    Marcucci, Maura
    Mannucci, Pier Mannuccio
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (10) : 1054 - 1060
  • [4] Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
    Kilit, Turkan Pasali
    Ozyigit, Filiz
    Erarslan, Sertas
    Onbasi, Kevser
    AFRICAN HEALTH SCIENCES, 2022, 22 (04) : 597 - 606
  • [5] Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
    Bachmann, Paula
    Frahm, Niklas
    Debus, Jane Louisa
    Mashhadiakbar, Pegah
    Langhorst, Silvan Elias
    Streckenbach, Barbara
    Baldt, Julia
    Heidler, Felicita
    Hecker, Michael
    Zettl, Uwe Klaus
    PHARMACEUTICS, 2022, 14 (03)
  • [6] Polypharmacy and the Risk of Drug-Drug Interactions in Patients with Rheumatoid Arthritis
    Krstic, Nikola
    Stefanovic, Nikola
    Petronijevic, Milan
    Damnjanovic, Ivana
    ACTA FACULTATIS MEDICAE NAISSENSIS, 2024, 41 (02) : 223 - 233
  • [7] Polypharmacy and the occurrence of potential drug-drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa
    Bojuwoye, Adetola Olaniyi
    Suleman, Fatima
    Perumal-Pillay, Velisha Ann
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2022, 15 (01)
  • [8] Medication Appropriateness, Polypharmacy, and Drug-Drug Interactions in Ambulatory Elderly Patients with Cardiovascular Diseases at Tikur Anbessa Specialized Hospital, Ethiopia
    Adem, Limi
    Tegegne, Gobezie T.
    CLINICAL INTERVENTIONS IN AGING, 2022, 17 : 509 - 517
  • [9] Potential drug-drug interactions in elderly patients presenting with syncope
    Gaeta, TJ
    Fiorini, M
    Ender, K
    Bove, J
    Diaz, J
    JOURNAL OF EMERGENCY MEDICINE, 2002, 22 (02) : 159 - 162
  • [10] Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002
    Haider, S. I.
    Johnell, K.
    Thorslund, M.
    Fastbom, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (12) : 643 - 653